Risk factors and a predictive model for the development of epilepsy after Japanese encephalitis

Dou-Dou Chen1, Xiao-Ling Peng2, Huan Cheng3

  • 1Department of Neurology, Children's Hospital of Chongqing Medical University, China; Ministry of Education Key Laboratory of Child Development and Disorders, China; National Clinical Research Center for Child Health and Disorders (Chongqing) China; China International Science and Technology Cooperation base of Child development and Critical Disorders China; Chongqing Key Laboratory of Pediatrics China.

Seizure
|May 31, 2022
PubMed

Insights

Seizures are common in children with Japanese encephalitis (JE). A new nomogram predicts post-encephalitic epilepsy (PEE) risk, aiding early intervention for better outcomes in pediatric JE patients.

Area of Science:

  • Pediatric Neurology
  • Infectious Diseases
  • Epileptology

Background:

  • Japanese encephalitis (JE) is a significant cause of neurological sequelae in children.
  • Seizures are a frequent complication during the acute phase of JE.
  • Post-encephalitic epilepsy (PEE) poses a long-term challenge for affected children.

Purpose of the Study:

  • To characterize seizure patterns in acute JE.
  • To identify risk factors for developing PEE.
  • To develop and validate a predictive model and nomogram for PEE risk.

Main Methods:

  • Retrospective analysis of 328 children with JE.
  • Univariable and multivariable logistic regression for risk factor identification.
  • Development and validation of a predictive nomogram using lasso regression and bootstrapping.

Main Results:

  • Seizures occurred in 65.9% of acute JE cases.
  • The incidence of PEE was 14.7%, with cumulative rates increasing over time.
  • Independent risk factors for PEE included seizure number >5, status epilepticus, and coma.
  • A validated nomogram demonstrated good predictive performance.

Conclusions:

  • Seizures are a common manifestation and sequela of JE in children.
  • The developed nomogram enables early PEE risk prediction.
  • Early prediction facilitates timely intervention, potentially improving long-term outcomes.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
298
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
629
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
695